Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The quick-implantable-defibrillator trial.

Dietmar Bänsch1, Hans Kottkamp, Gerian Grönefeld

  • 1Department of Cardiology, St. Georg's Hospital, Hamburg, Germany. dietmarbaensch@alice-dsl.de

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|October 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fundamental Anatomy and Its Impact on Clinical Practice: The Rightward Extension of Bachmann's Bundle (Part II-III).

JACC. Case reports·2026
Same author

Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study.

Pacing and clinical electrophysiology : PACE·2026
Same author

[2023 Annual Report of the German Pacemaker and Defibrillator Register-Part 2: Implantable cardioverter defibrillators (ICD)].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

Rebuttal to: "Comment on the CORRECT RADIAL trial: considerations on methodology and interpretation." (CRCD-D-26-00099).

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

[Annual report 2023 of the German Pacemaker and Defibrillator Register-Part 1: Cardiac pacemaker].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

Pulsed field ablation: The pitfall of remote stunning or the importance of contact and contiguity.

Heart rhythm O2·2026
Same journal

Removal of tine-based leadless pacemakers - Insights from a large multicenter experience.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Insulin-treated type 2 diabetes is associated with increased mortality after transvenous lead extraction for device infection: the IN2DEEP study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Incidence and Clinical Predictors of Cognitive Decline in Anticoagulated Patients with Atrial Fibrillation. The Strat-AF Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation - insights from acute and chronic electroanatomic remapping in the randomized SINGLE-SHOT CHAMPION trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Pulmonary vein reconnection patterns after pentaspline pulsed field ablation for atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Angioplasty for Pulmonary Vein Stenosis after Atrial Fibrillation Ablation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
See all related articles

Simplifying implantable cardioverter-defibrillator (ICD) implantation by omitting electrophysiological studies (EPS) and extensive defibrillation threshold tests (DFT) is safe and effective for patients who survived cardiac arrest or ventricular tachycardia. This approach reduces hospital stay without compromising patient outcomes.

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Trials

Background:

  • Implantable cardioverter-defibrillator (ICD) implantation protocols have evolved, with many centers reducing or eliminating electrophysiological studies (EPS), extensive defibrillation threshold tests (DFT), and pre-discharge tests.
  • The safety and efficacy of these simplified ICD implantation strategies have not been prospectively demonstrated.

Purpose of the Study:

  • To prospectively evaluate the safety and effectiveness of a simplified ICD implantation strategy compared to an extensive strategy in patients who survived sudden cardiac arrest (SCA) or unstable ventricular tachycardia (VT).

Main Methods:

  • The Quick-Implantable-Defibrillator (Quick-ICD) Trial was a prospective, multi-center study randomizing 190 patients to either an extensive strategy (including EPS, extensive DFT, and pre-discharge test) or a quick strategy (ICD implantation without EPS and pre-discharge test, with two 21 J shocks).

Related Experiment Videos

  • The primary endpoint was a composite of adverse events related to the diagnostic approach and ICD therapy.
  • Patients were followed for a mean of 12 months.

    • Main Results:

    • Event-free survival was equivalent between the quick strategy group (27 events) and the extensive strategy group (32 events) (P = 0.0044 for equivalence).
    • The initial hospital stay was significantly shorter in the quick strategy group (8.4 days) compared to the extensive strategy group (11.2 days) (P = 0.004).

    Conclusions:

    • A simplified ICD implantation protocol, omitting electrophysiological studies (EPS), extensive defibrillation threshold tests (DFT), and pre-discharge tests, is safe and cost-effective in carefully selected patients post-sudden cardiac arrest (SCA) or ventricular tachycardia (VT).
    • This streamlined approach leads to shorter hospitalizations without compromising patient safety or treatment efficacy.